Final Rules

• Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2015

  

• Medicare Program; Inpatient Psychiatric Facilities Prospective Payment System-Update for Fiscal Year Beginning October 1, 2014 (FY 2015)

  

• Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities for FY 2015

  

• Administrative Simplification: Change to the Compliance Date for the International Classification of Diseases, 10th Revision (ICD-10-CM and ICD-10-PCS) Medical Data Code Sets

  

• Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Fiscal Year 2014 Rates; Quality Reporting Requirements for Specific Providers; Hospital Conditions of

  

• Patient Protection and Affordable Care Act; Exchange and Insurance Market Standards for 2015 and Beyond; Correction

  

• New Animal Drugs Afoxalaner Ceftiofur Crystalline Free Acid Chloramine-T Clodronate Enrofloxacin Eprinomectin Fluralaner Ivermectin and Praziquantel Niclosamide Ractopamine Tylosin Change of Sponsors Address

  

• Patient Protection and Affordable Care Act; Program Integrity: Exchange, Premium Stabilization Programs, and Market Standards; Amendments to the HHS Notice of Benefit and Payment Parameters for 2014; Correcting Amendment

  

• Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2015; Correcting Amendment

  

• Ninety-Day Waiting Period Limitation

  

• Guidance for Industry Demonstration of the Quality Factor Requirements for Eligible Infant Formulas; Availability

  

• Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements

  

• Maximum Civil Money Penalty Amounts; Civil Money Penalty Complaints; Confirmation of Effective Date

  

• Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act

  

• Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions

  

• General and Plastic Surgery Devices: Reclassification of Ultraviolet Lamps for Tanning, Henceforth To Be Known as Sunlamp Products and Ultraviolet Lamps Intended for Use in Sunlamp Products

  

• Microbiology Devices; Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis Complex in Respiratory Specimens

  

• Administrative Detention of Drugs Intended for Human or Animal Use

  

• Medicare Program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs

  

• Patient Protection and Affordable Care Act; Exchange and Insurance Market Standards for 2015 and Beyond